- Home
- EBMT vs LUNG Comparison
EBMT vs LUNG Comparison
Compare EBMT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- LUNG
- Stock Information
- Founded
- EBMT 1922
- LUNG 1995
- Country
- EBMT United States
- LUNG United States
- Employees
- EBMT N/A
- LUNG N/A
- Industry
- EBMT Major Banks
- LUNG Industrial Specialties
- Sector
- EBMT Finance
- LUNG Health Care
- Exchange
- EBMT Nasdaq
- LUNG Nasdaq
- Market Cap
- EBMT 127.9M
- LUNG 124.0M
- IPO Year
- EBMT N/A
- LUNG 2020
- Fundamental
- Price
- EBMT $15.92
- LUNG $2.63
- Analyst Decision
- EBMT
- LUNG Buy
- Analyst Count
- EBMT 0
- LUNG 6
- Target Price
- EBMT N/A
- LUNG $11.53
- AVG Volume (30 Days)
- EBMT 45.5K
- LUNG 359.5K
- Earning Date
- EBMT 07-22-2025
- LUNG 07-30-2025
- Dividend Yield
- EBMT 3.58%
- LUNG N/A
- EPS Growth
- EBMT 26.99
- LUNG N/A
- EPS
- EBMT 1.41
- LUNG N/A
- Revenue
- EBMT $82,271,000.00
- LUNG $87,473,000.00
- Revenue This Year
- EBMT N/A
- LUNG $18.02
- Revenue Next Year
- EBMT $4.97
- LUNG $18.17
- P/E Ratio
- EBMT $11.29
- LUNG N/A
- Revenue Growth
- EBMT 0.06
- LUNG 19.84
- 52 Week Low
- EBMT $12.61
- LUNG $2.51
- 52 Week High
- EBMT $18.49
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- EBMT 40.04
- LUNG 33.86
- Support Level
- EBMT $15.10
- LUNG $2.51
- Resistance Level
- EBMT $16.86
- LUNG $2.80
- Average True Range (ATR)
- EBMT 0.43
- LUNG 0.21
- MACD
- EBMT -0.05
- LUNG 0.00
- Stochastic Oscillator
- EBMT 39.81
- LUNG 11.43
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.